Data / Medical devices / Probe, Radiofrequency Lesion

Probe, Radiofrequency Lesion (GXI): 51 FDA-registered makers in 13 countries

51 establishments in 13 countries are registered with the FDA to make Probe, Radiofrequency Lesion (product code GXI, Class 2, 21 CFR 882.4725). 24 of them have a 510(k) clearance or PMA approval on file and 5 have a recall event. The FDA has issued 66 510(k) clearances under this code, the latest on April 16, 2026, and lists 16 recall events (0 Class I). FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

Product code

GXI

Device class

2

Regulation

882.4725

Medical specialty

Neurology

Makers by country

Makers of Probe, Radiofrequency Lesion

Registered establishments that manufacture, contract manufacture, remanufacture, reprocess or own the specification of this device, with the 510(k) clearances, PMA approvals and recalls the FDA files under each. Best documented first.

Updated April 16, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.